4
Changes in Ownership
Nautilus Biotechnology, Inc. Filed Acc 0001062993-21-007983
Director bought 36,970 shares at an average $7.71 ($285,041)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McIlwain Matthew S Director | 2021-08-24 | Purchase | +13,568 | $7.68 | $104,269 | 335,673 | D: show line 1 in the form |
| McIlwain Matthew S Director | 2021-08-25 | Purchase | +11,693 | $7.74 | $90,458 | 347,366 | D: show line 2 in the form |
| McIlwain Matthew S Director | 2021-08-26 | Purchase | +11,709 | $7.71 | $90,314 | 359,075 | D: show line 3 in the form |
| Open-market purchases · 36,970 sh · avg $7.71 · $285,041 | |||||||
Loading xslF345X03/form4.xml…